T LYMPHOBLASTIC LYMPHOMA
Clinical trials for T LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could adding daratumumab to chemo beat tough blood cancers?
Disease control Not yet recruitingThis study tests whether adding daratumumab (a drug that helps the immune system attack cancer cells) to standard chemotherapy can improve outcomes for children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. About 1,700…
Matched conditions: T LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Engineered immune cells aim to stop relapse in young blood cancer patients
Disease control Not yet recruitingThis early-phase trial tests a new treatment called CD7 CAR-T cell therapy for 10 children with high-risk T-cell leukemia or lymphoma. After initial chemotherapy puts the cancer into remission, the child's own immune cells are collected, engineered to target cancer cells, and giv…
Matched conditions: T LYMPHOBLASTIC LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 22, 2026 13:51 UTC